Rubric Capital Management
Latest statistics and disclosures from Rubric Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TEVA, VTRS, ROIV, GLNG, BGC, and represent 29.10% of Rubric Capital Management's stock portfolio.
- Added to shares of these 10 stocks: QDEL (+$101M), ROIV (+$100M), Ishares Bitcoin Tr (+$70M), LBTYA (+$65M), VTRS (+$62M), VYX (+$57M), SSYS (+$48M), VST (+$43M), EXTR (+$40M), PLAY (+$38M).
- Started 21 new stock positions in Ishares Bitcoin Tr, LBTYK, EXTR, GDRX, PLAY, CAR, CHRS, Coherus Biosciences, ATMU, LBTYA. CRS, NUVL, VYX, SDGR, PTGX, CNNE, MD, OPK, XERS, ADPT, SWTX.
- Reduced shares in these 10 stocks: IWM (-$265M), , HTZ (-$63M), COLL (-$52M), NRG (-$51M), PARR (-$45M), , COOP (-$35M), KOP (-$31M), MGNI (-$30M).
- Sold out of its positions in AHCO, CCJ, CCO, CNDT, HTZ, IMVT, IWM, MSGS, MX, MGNI. NRG, PCRX, STRO, HOLI.
- Rubric Capital Management was a net buyer of stock by $203M.
- Rubric Capital Management has $3.4B in assets under management (AUM), dropping by 26.91%.
- Central Index Key (CIK): 0001687509
Tip: Access up to 7 years of quarterly data
Positions held by Rubric Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Rubric Capital Management
Rubric Capital Management holds 68 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 7.4 | $249M | -7% | 18M | 14.11 |
|
| Viatris (VTRS) | 6.5 | $220M | +39% | 18M | 11.94 |
|
| Roivant Sciences SHS (ROIV) | 6.2 | $211M | +90% | 20M | 10.54 |
|
| Golar Lng SHS (GLNG) | 4.6 | $157M | 6.5M | 24.06 |
|
|
| Bgc Group Cl A (BGC) | 4.4 | $148M | -5% | 19M | 7.77 |
|
| Mr Cooper Group (COOP) | 3.5 | $118M | -22% | 1.5M | 77.95 |
|
| Quidel Corp (QDEL) | 3.4 | $115M | +709% | 2.4M | 47.94 |
|
| Fluor Corporation (FLR) | 3.2 | $110M | +9% | 2.6M | 42.28 |
|
| Vistra Energy (VST) | 2.5 | $85M | +101% | 1.2M | 69.65 |
|
| Constellium Se Cl A Shs (CSTM) | 2.4 | $80M | +85% | 3.6M | 22.11 |
|
| Pactiv Evergreen (PTVE) | 2.3 | $79M | +10% | 5.5M | 14.32 |
|
| Schweitzer-Mauduit International (MATV) | 2.2 | $75M | 4.0M | 18.75 |
|
|
| Arcutis Biotherapeutics (ARQT) | 2.2 | $74M | +49% | 7.5M | 9.91 |
|
| Heron Therapeutics (HRTX) | 2.2 | $74M | 27M | 2.77 |
|
|
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.1 | $71M | -42% | 1.8M | 38.82 |
|
| Renew Energy Global Cl A Shs (RNW) | 2.1 | $70M | +18% | 12M | 6.00 |
|
| Ishares Bitcoin Tr SHS | 2.1 | $70M | NEW | 1.7M | 40.47 |
|
| Biosante Pharmaceuticals (ANIP) | 2.0 | $66M | +13% | 959k | 69.13 |
|
| Liberty Global Com Cl A (LBTYA) | 1.9 | $65M | NEW | 3.8M | 16.92 |
|
| Dole Ord Shs (DOLE) | 1.8 | $61M | +37% | 5.1M | 11.93 |
|
| Stratasys SHS (SSYS) | 1.7 | $59M | +454% | 5.1M | 11.62 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.7 | $58M | +137% | 9.5M | 6.06 |
|
| NCR Corporation (VYX) | 1.7 | $57M | NEW | 4.5M | 12.63 |
|
| Orthofix Medical (OFIX) | 1.6 | $53M | +6% | 3.7M | 14.52 |
|
| Adeia (ADEA) | 1.5 | $51M | 4.6M | 10.92 |
|
|
| Xperi Common Stock (XPER) | 1.4 | $49M | 4.0M | 12.06 |
|
|
| Mereo Biopharma Group Spon Ads (MREO) | 1.3 | $45M | +16% | 14M | 3.30 |
|
| Aar (AIR) | 1.3 | $43M | -40% | 725k | 59.87 |
|
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 1.3 | $43M | -28% | 2.2M | 19.73 |
|
| Playa Hotels & Resorts Nv SHS (PLYA) | 1.2 | $40M | -20% | 4.2M | 9.70 |
|
| Extreme Networks (EXTR) | 1.2 | $40M | NEW | 3.5M | 11.54 |
|
| Dave & Buster's Entertainmnt (PLAY) | 1.1 | $38M | NEW | 599k | 62.60 |
|
| Zymeworks Del (ZYME) | 1.1 | $37M | +31% | 3.5M | 10.52 |
|
| Atmus Filtration Technologies Ord (ATMU) | 1.1 | $37M | NEW | 1.1M | 32.25 |
|
| Adaptive Biotechnologies Cor (ADPT) | 1.0 | $34M | NEW | 11M | 3.21 |
|
| Liberty Global Com Cl C (LBTYK) | 1.0 | $33M | NEW | 1.9M | 17.64 |
|
| Koppers Holdings (KOP) | 0.9 | $32M | -49% | 573k | 55.17 |
|
| Transalta Corp (TAC) | 0.9 | $30M | +6% | 4.7M | 6.43 |
|
| Par Pac Holdings Com New (PARR) | 0.8 | $29M | -60% | 772k | 37.06 |
|
| Cannae Holdings (CNNE) | 0.8 | $27M | NEW | 1.2M | 22.24 |
|
| Schrodinger (SDGR) | 0.8 | $27M | NEW | 998k | 27.00 |
|
| Avis Budget (CAR) | 0.8 | $26M | NEW | 215k | 122.46 |
|
| Coherus Biosciences (CHRS) | 0.7 | $25M | NEW | 10M | 2.39 |
|
| Riskified Shs Cl A (RSKD) | 0.7 | $23M | +159% | 4.2M | 5.41 |
|
| Springworks Therapeutics (SWTX) | 0.6 | $21M | NEW | 427k | 49.22 |
|
| Ftai Infrastructure Common Stock (FIP) | 0.6 | $20M | 3.2M | 6.28 |
|
|
| Nuvalent Inc-a (NUVL) | 0.6 | $20M | NEW | 262k | 75.09 |
|
| Trevi Therapeutics (TRVI) | 0.6 | $19M | -2% | 5.6M | 3.45 |
|
| Scpharmaceuticals (SCPH) | 0.5 | $18M | +29% | 3.5M | 5.02 |
|
| Ovid Therapeutics (OVID) | 0.5 | $16M | -2% | 5.3M | 3.05 |
|
| Omniab (OABI) | 0.5 | $16M | 2.9M | 5.42 |
|
|
| Goodrx Hldgs Com Cl A (GDRX) | 0.4 | $15M | NEW | 2.1M | 7.10 |
|
| Ardelyx (ARDX) | 0.4 | $13M | -27% | 1.8M | 7.30 |
|
| Revance Therapeutics (RVNC) | 0.4 | $13M | +66% | 2.7M | 4.92 |
|
| Cullinan Oncology (CGEM) | 0.3 | $11M | 627k | 17.04 |
|
|
| Werewolf Therapeutics (HOWL) | 0.3 | $11M | -16% | 1.6M | 6.48 |
|
| Mednax (MD) | 0.3 | $9.1M | NEW | 909k | 10.03 |
|
| Telesat Corp Cl A & Cl B Shs (TSAT) | 0.2 | $8.2M | 960k | 8.52 |
|
|
| Playstudios Class A Com (MYPS) | 0.2 | $6.6M | +20% | 2.4M | 2.78 |
|
| Silverback Therapeutics (SPRY) | 0.2 | $6.5M | 639k | 10.22 |
|
|
| Opko Health (OPK) | 0.2 | $5.9M | NEW | 4.9M | 1.20 |
|
| Protagonist Therapeutics (PTGX) | 0.2 | $5.7M | NEW | 198k | 28.93 |
|
| Carpenter Technology Corporation (CRS) | 0.2 | $5.6M | NEW | 79k | 71.42 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.2 | $5.1M | 205k | 24.90 |
|
|
| Therapeuticsmd Com New (TXMD) | 0.1 | $2.7M | 1.2M | 2.29 |
|
|
| Coherus Biosciences Note 1.500% 4/1 (Principal) | 0.0 | $1.6M | NEW | 2.5M | 0.64 |
|
| Xeris Pharmaceuticals (XERS) | 0.0 | $687k | NEW | 311k | 2.21 |
|
| Vincerx Pharma Com New (VINC) | 0.0 | $591k | -67% | 117k | 5.06 |
|
Past Filings by Rubric Capital Management
SEC 13F filings are viewable for Rubric Capital Management going back to 2016
- Rubric Capital Management 2024 Q1 filed May 10, 2024
- Rubric Capital Management 2023 Q3 restated filed Nov. 15, 2023
- Rubric Capital Management 2023 Q3 filed Nov. 14, 2023
- Rubric Capital Management 2023 Q2 filed Aug. 11, 2023
- Rubric Capital Management 2023 Q1 filed May 12, 2023
- Rubric Capital Management 2022 Q4 filed Feb. 10, 2023
- Rubric Capital Management 2022 Q3 filed Nov. 14, 2022
- Rubric Capital Management 2022 Q2 restated filed Aug. 15, 2022
- Rubric Capital Management 2022 Q2 filed Aug. 12, 2022
- Rubric Capital Management 2022 Q1 filed May 13, 2022
- Rubric Capital Management 2021 Q4 filed Feb. 14, 2022
- Rubric Capital Management 2021 Q3 filed Nov. 12, 2021
- Rubric Capital Management 2021 Q2 filed Aug. 13, 2021
- Rubric Capital Management 2021 Q1 filed May 14, 2021
- Rubric Capital Management 2020 Q4 filed Feb. 16, 2021
- Rubric Capital Management 2020 Q3 filed Nov. 13, 2020